FindTrial
Sign In

Effect evaluation of Reverse diabetes type 2 program by Voeding Leeft

Effect evaluation of Reverse diabetes type 2 program by Voeding Leeft - Evaluation *Reverse diabetes type 2 program*

Status
Unknown
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON45893
Enrollment
300
Registered
2018-11-20
Start date
Unknown
Completion date
Unknown
Last updated
2024-04-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diabetes mellitus

Interventions

None listed

Sponsors

Louis Bolk Instituut
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: All participants of the Voeding Leeft program can participate in this evaluation study.

Exclusion criteria

Exclusion criteria: None.

Design outcomes

Primary

MeasureTime frame
Self-reported HbA1c values and medication use assessed via online questionnaires.—

Secondary

MeasureTime frame
Other than HbA1c self-reported T2D biomarkers, subjective health parameters, sleep, dietary intake, physical activity and program adherence.—

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)